Reading the tape
NYSE: TFX
Teleflex Incorporated
Healthcare · Medical - Instruments & Supplies
Market Cap
$5.27B
52w High
$139.67
52w Low
$100.18
P/E
-5.82
Volume
82.07K
Outstanding Shares
44.27M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -2.45%Revenue (TTM): -2.75%FCF (TTM): -51.81%P/FCF: 13th pct
What changed
The stock fell 2.45% over the last year. Revenue declined 2.75% over the trailing twelve months. Operating margin moved from 4.96% to 9.7%. Free cash flow declined 51.81% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 9.7%. A decisive move in revenue — currently down 2.75% — would be the clearest signal to resolve the ambiguity.
Company profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
CEOStuart A. Randle
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees14,100
IPO dateMar 17, 1980
Valuation
Forward P/E—
EV/EBITDA25.71
Enterprise value$7.78B
Stock splits
Jun 17, 1997↑ Forward
Every 1 shares became 2
Jun 17, 1991↑ Forward
Every 2 shares became 3
Jun 17, 1986↑ Forward
Every 1 shares became 2
Sep 16, 1981↑ Forward
Every 2 shares became 3
Dec 16, 1980↑ Forward
Every 1 shares became 2
Jun 16, 1978↑ Forward
Every 1 shares became 2
Jan 20, 1977↑ Forward
Every 20 shares became 21
Jan 9, 1976↑ Forward
Every 1000 shares became 1049
Profitability & growth
Revenue growth-28.47%
Gross margin53.3%▲0.66%vs FY2024
Operating margin9.7%▲159.04%vs FY2024
ROE-28.98%▼1879.57%vs FY2024
Analyst consensus
RatingBuy
Target price$132.20▲10.97%
14
Buy
14
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est $1.21 · Revenue est $537.6M
View
Dividends
$1.36/shareQuarterlyDividend Aristocrat · 30yrSafeTFX pays a dividend with a 1.14% dividend yield, 30 consecutive years of growth, covered 4.1× by free cash flow.
Dividend Yield
1.14%
Annual Div / Share
$1.36
5yr CAGR
+0%
Payout Ratio
—
Safe
Dividend Growth Rate
3yr CAGR
+0%
5yr CAGR
+0%
10yr CAGR
+0%
Dividend Safety
10/10Safe
Dividend History
Annual dividends paid per share
YearAnnual DivYoY
2025$1.36+0.0%
2024$1.36+0.0%
2023$1.36+0.0%
2022$1.36+0.0%
2021$1.36+0.0%
2020$1.36+0.0%
2019$1.36+0.0%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$11/yr
$1/mo
In 5 yrs
$11/yr
$1/mo
In 10 yrs
$11/yr
$1/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$11/yr $1/mo | $11/yr $1/mo | $11/yr $1/mo |
Analysis
Dividend Strengths
Dividend Aristocrat
TFX has raised its dividend for 30 consecutive years — qualifying as a Dividend Aristocrat, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 4.1× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.